Systematic review of HIV and HCV infection among drug users in China.
about
Risk Factors of HIV and Other Sexually Transmitted Infections in China: A Systematic Review of ReviewsHepatitis B and C virus infection and hepatocellular carcinoma in China: a review of epidemiology and control measuresHCV Diversity among Chinese and Burmese IDUs in Dehong, Yunnan, ChinaPhylogeographic analyses reveal a crucial role of Xinjiang in HIV-1 CRF07_BC and HCV 3a transmissions in AsiaComparison of HIV-, HBV-, HCV- and co-infection prevalence between Chinese and Burmese intravenous drug users of the China-Myanmar border regionHCV subtype characterization among injection drug users: implication for a crucial role of Zhenjiang in HCV transmission in ChinaHigh prevalence of HIV, HCV, HBV and co-infection and associated risk factors among injecting drug users in Yunnan province, ChinaHCV and HIV infection among heroin addicts in methadone maintenance treatment (MMT) and not in MMT in Changsha and Wuhan, ChinaHIV and hepatitis C virus testing delays at methadone clinics in Guangdong Province, ChinaHigh prevalence of HIV, HCV and tuberculosis and associated risk behaviours among new entrants of methadone maintenance treatment clinics in Guangdong Province, ChinaLong-term effects of methadone maintenance treatment with different psychosocial intervention modelsBaseline HCV Antibody Prevalence and Risk Factors among Drug Users in China's National Methadone Maintenance Treatment ProgramNatural Polymorphisms Conferring Resistance to HCV Protease and Polymerase Inhibitors in Treatment-Naïve HIV/HCV Co-Infected Patients in ChinaPolicy implementation of methadone maintenance treatment and HIV infection: evidence from Hubei province, China.The Chinese government's response to drug use and HIV/AIDS: a review of policies and programs.Social justice and HIV vaccine research in the age of pre-exposure prophylaxis and treatment as preventionNeedle and syringe programs in Yunnan, China yield health and financial returnTrends in notifiable infectious diseases in China: implications for surveillance and population health policy.Rural-to-urban migrants are at high risk of sexually transmitted and viral hepatitis infections in China: a systematic review and meta-analysisHIV and HCV prevalence among entrants to methadone maintenance treatment clinics in China: a systematic review and meta-analysis.HIV infection risk among injection drug users in a methadone maintenance treatment program, Taipei, Taiwan 2007-2010.Prevalences and associated risk factors of HCV/HIV co-infection and HCV mono-infection among injecting drug users in a methadone maintenance treatment program in Taipei, Taiwan.Epidemiology of hepatitis C virus infection in highly endemic HBV areas in China.Exploring the social meaning of curing HIV: a qualitative study of people who inject drugs in Guangzhou, China.Methadone maintenance treatment participant retention and behavioural effectiveness in China: a systematic review and meta-analysisHIV and hepatitis C virus test uptake at methadone clinics in Southern China: opportunities for expanding detection of bloodborne infectionsBurden of blood transmitted infections in substance users admitted for inpatient treatment in Singapore and the associated factors.Drug treatment as HIV prevention: a research updateDrug treatment as HIV prevention: expanding treatment options.Hepatitis C among methadone maintenance treatment patients in Shanghai and Kunming, ChinaHIV, syphilis, hepatitis C and risk behaviours among commercial sex male clients in Sichuan province, China.Genotypic distribution and hepatic fibrosis among HIV/HCV co-infected individuals in Southern China: a retrospective cross-sectional studyHepatitis C seroconversion in methadone maintenance treatment programs in Wuhan, China.Plasma Hepatitis C Virus Viral Load Among Hepatitis C Virus Mono-Infected and HCV/HIV Co-Infected Individuals in Yunnan Province,China.Describing the Chinese HIV surveillance system and the influences of political structures and social stigma.An intervention targeting service providers and clients for methadone maintenance treatment in China: a cluster-randomized trialHigh Prevalence of Hepatitis C virus Among Injection Drug Users in Zhenjiang, Jiangsu, ChinaTriple positivity of HBsAg, anti-HCV antibody, and HIV and their influence on CD4+ lymphocyte levels in the highly HIV infected population of Abeokuta, Nigeria.Understanding differences in HIV/HCV prevalence according to differentiated risk behaviors in a sample of PWID in rural Puerto RicoThe association between the genetic polymorphisms of LMP2/LMP7 and the outcomes of HCV infection among drug users.
P2860
Q26782790-15C6C805-6D4B-493E-8CB5-12CE958A29FEQ26829313-B21C6C41-617E-4F01-8A79-F92347365D04Q27468608-1A17F9CC-1D19-4121-A274-F1870D51DFEBQ28476536-789CDCAD-E306-4689-8854-8362E95C3F60Q28476802-CB7179D0-2B84-404E-AFA0-2B7E97904804Q28477079-28A57C3D-5847-47AB-A167-357D917C48D4Q28482312-B0A1F826-F6D3-4937-94C7-697B78B6AF02Q28483942-9BB19485-140A-4ADB-BC59-6B42AE2EAC4FQ28534017-BA618E3F-B095-45AB-BC39-1DF34F0857BAQ28534213-80F49125-583E-45B9-8FEA-E6BF04511B0FQ28539468-D292A03F-396F-4330-9523-49E577FE2487Q28550339-1B68F411-9386-4764-BACE-AB6554C710A5Q28552134-90703BA3-39DA-4FD5-A641-1A216B004B7FQ30390704-6A3552F9-5839-4E28-951F-0DC479A9A99BQ33761624-7E0F6E7F-3760-4F52-BBBF-975DE5FA9EB7Q33854562-21B59814-B6DC-4377-A479-3C36ACAFCF99Q33877970-CB559A65-19B8-4B92-A55F-8722F58B6A9EQ34168122-9AED563D-5F04-4B30-9109-97C3658E6D5CQ34217353-AF9E82F4-C1FC-4142-B863-F0B4A063A9DCQ34297996-4C7753FF-311B-4D3F-8DA0-381A87E540B5Q34498325-1A8D3DFC-BCCC-4294-A207-CBAB622B0F99Q34507544-9921DD1B-3178-41A8-8A2C-0B6CB87478F6Q34571364-E0A46B82-CA8E-4764-96C2-5E31F349FDBFQ34869495-A5EC96CD-FD3D-477C-9BED-E93D69DD7F2EQ34901860-18E46632-BAAB-4BB4-9155-247698307290Q35002184-FD0D442C-65A1-422A-87FC-1A721138C788Q35150028-DC71B6FC-17A4-4AF6-936C-C9B2E8CE692EQ35163392-45511A37-F357-4D8D-8545-1D5AF5A0C673Q35163396-57BEB808-CACB-4A00-B8B0-9739D44BD116Q35773225-C3647633-28B8-43FF-AAEA-7C9A7146A0B0Q35805443-2E05E82E-17E5-4110-8468-D57735D5DA24Q36110233-EE555522-A4ED-40BF-9247-AB3680A20510Q36137709-46932B72-C8B8-41D8-A97A-8A4CD9BE4ADDQ36220218-15949146-5646-4932-AA86-3A8EC8873938Q36291586-73F324EC-6191-4EC2-8C8D-6758863C3F62Q36354260-14F22C52-43B4-4CE8-92C2-7CF0072778B7Q36550056-15A9A0B2-87C7-42CA-BA6A-DD78BDDADF15Q36612848-4391D32F-9318-4D1D-A3A5-6EADA2C95FA9Q36668343-28BA294E-5714-4711-BB39-E6605FE321C6Q36681912-8D7E8814-1367-4A4B-B8F8-E121BB05629E
P2860
Systematic review of HIV and HCV infection among drug users in China.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Systematic review of HIV and HCV infection among drug users in China.
@en
Systematic review of HIV and HCV infection among drug users in China.
@nl
type
label
Systematic review of HIV and HCV infection among drug users in China.
@en
Systematic review of HIV and HCV infection among drug users in China.
@nl
prefLabel
Systematic review of HIV and HCV infection among drug users in China.
@en
Systematic review of HIV and HCV infection among drug users in China.
@nl
P2860
P356
P1476
Systematic review of HIV and HCV infection among drug users in China.
@en
P2860
P304
P356
10.1258/IJSA.2008.008362
P577
2009-06-01T00:00:00Z